SmartMouth Advanced Clinical Formula Clinical Research Design Protocol
Status:
Completed
Trial end date:
2017-05-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to provide evidence on the clinical efficacy of SmartMouth Advanced
Clinical Formula mouthrinse in comparison to the efficacy of 0.12% chlorhexidine mouthrinse
and a placebo mouthrinse. The placebo will be provided by the sponsor and will be identical
to SmartMouth ACF (Advanced Clinical Formula), except it will not contain cetylpyridinium
chloride, zinc chloride and sodium chlorite. The primary outcomes include measures of plaque
and gingivitis. Secondary outcomes include evaluation of tooth discoloration, taste
perception, malodor and calculus.